FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285097462> ?p ?o ?g. }

• W4285097462 endingPage "1167" @default.
• W4285097462 startingPage "1162" @default.
• W4285097462 abstract "There is no consensus on the management of immune checkpoint inhibitor (ICI) for treating cancer in patients with pre-existing inflammatory bowel disease (IBD). The Groupe d'Étude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID) aimed to provide recommendations on this topic.A dedicated working group performed a comprehensive expert-based review of the literature, generated clinical key question and shaped recommendations that were further voted for approval by the educational and scientific committees of the GETAID. Using consensus methods, treatment modalities were defined by vote.Majority of patients with IBD in clinical remission can be treated with ICI after cancer diagnosis. The rate of relapse or immune-related diarrhoea or colitis upon ICI treatment is up to 39.8% and is maximal with ICI combination therapy compared to monotherapies. When starting ICI in a patient with IBD, it is recommended to assess disease activity and pursue ongoing maintenance therapy. In case of relapse or immune-related diarrhoea or colitis upon ICI treatment, treatment depends on grading of diarrhoea or colitis and may include corticosteroid therapy, infliximab and/or vedolizumab.In the present publication, we provided recommendations, which may assist gastroenterologists, haematologists, and oncologists for a better management of patients with pre-existing IBD before and during cancer treatment with ICI." @default.
• W4285097462 created "2022-07-14" @default.
• W4285097462 creator A5009680823 @default.
• W4285097462 creator A5014407122 @default.
• W4285097462 creator A5038935670 @default.
• W4285097462 creator A5054590261 @default.
• W4285097462 creator A5081540419 @default.
• W4285097462 date "2022-09-01" @default.
• W4285097462 modified "2023-09-30" @default.
• W4285097462 title "Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID" @default.
• W4285097462 cites W1547943993 @default.
• W4285097462 cites W2165456770 @default.
• W4285097462 cites W2185075416 @default.
• W4285097462 cites W2523706394 @default.
• W4285097462 cites W2580505605 @default.
• W4285097462 cites W2583633660 @default.
• W4285097462 cites W2594042408 @default.
• W4285097462 cites W2601055810 @default.
• W4285097462 cites W2766903152 @default.
• W4285097462 cites W2781601010 @default.
• W4285097462 cites W2793180707 @default.
• W4285097462 cites W2793304410 @default.
• W4285097462 cites W2794281764 @default.
• W4285097462 cites W2885781276 @default.
• W4285097462 cites W2888695906 @default.
• W4285097462 cites W2976362764 @default.
• W4285097462 cites W2994201430 @default.
• W4285097462 cites W3003593158 @default.
• W4285097462 cites W3004033817 @default.
• W4285097462 cites W3034088091 @default.
• W4285097462 cites W3034596577 @default.
• W4285097462 cites W3092802874 @default.
• W4285097462 cites W3106005610 @default.
• W4285097462 cites W3128491738 @default.
• W4285097462 cites W3130011706 @default.
• W4285097462 cites W3134238388 @default.
• W4285097462 cites W3158048560 @default.
• W4285097462 cites W3174333127 @default.
• W4285097462 cites W3215621197 @default.
• W4285097462 cites W4210690867 @default.
• W4285097462 cites W4211138554 @default.
• W4285097462 doi "https://doi.org/10.1016/j.dld.2022.06.020" @default.
• W4285097462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35842365" @default.
• W4285097462 hasPublicationYear "2022" @default.
• W4285097462 type Work @default.
• W4285097462 citedByCount "6" @default.
• W4285097462 countsByYear W42850974622023 @default.
• W4285097462 crossrefType "journal-article" @default.
• W4285097462 hasAuthorship W4285097462A5009680823 @default.
• W4285097462 hasAuthorship W4285097462A5014407122 @default.
• W4285097462 hasAuthorship W4285097462A5038935670 @default.
• W4285097462 hasAuthorship W4285097462A5054590261 @default.
• W4285097462 hasAuthorship W4285097462A5081540419 @default.
• W4285097462 hasBestOaLocation W42850974621 @default.
• W4285097462 hasConcept C121608353 @default.
• W4285097462 hasConcept C126322002 @default.
• W4285097462 hasConcept C127413603 @default.
• W4285097462 hasConcept C147176958 @default.
• W4285097462 hasConcept C177713679 @default.
• W4285097462 hasConcept C2775862500 @default.
• W4285097462 hasConcept C2776207728 @default.
• W4285097462 hasConcept C2777138892 @default.
• W4285097462 hasConcept C2777286243 @default.
• W4285097462 hasConcept C2778260677 @default.
• W4285097462 hasConcept C2779134260 @default.
• W4285097462 hasConcept C2780479503 @default.
• W4285097462 hasConcept C526805850 @default.
• W4285097462 hasConcept C71924100 @default.
• W4285097462 hasConcept C90924648 @default.
• W4285097462 hasConceptScore W4285097462C121608353 @default.
• W4285097462 hasConceptScore W4285097462C126322002 @default.
• W4285097462 hasConceptScore W4285097462C127413603 @default.
• W4285097462 hasConceptScore W4285097462C147176958 @default.
• W4285097462 hasConceptScore W4285097462C177713679 @default.
• W4285097462 hasConceptScore W4285097462C2775862500 @default.
• W4285097462 hasConceptScore W4285097462C2776207728 @default.
• W4285097462 hasConceptScore W4285097462C2777138892 @default.
• W4285097462 hasConceptScore W4285097462C2777286243 @default.
• W4285097462 hasConceptScore W4285097462C2778260677 @default.
• W4285097462 hasConceptScore W4285097462C2779134260 @default.
• W4285097462 hasConceptScore W4285097462C2780479503 @default.
• W4285097462 hasConceptScore W4285097462C526805850 @default.
• W4285097462 hasConceptScore W4285097462C71924100 @default.
• W4285097462 hasConceptScore W4285097462C90924648 @default.
• W4285097462 hasIssue "9" @default.
• W4285097462 hasLocation W42850974621 @default.
• W4285097462 hasLocation W42850974622 @default.
• W4285097462 hasLocation W42850974623 @default.
• W4285097462 hasOpenAccess W4285097462 @default.
• W4285097462 hasPrimaryLocation W42850974621 @default.
• W4285097462 hasRelatedWork W2790575954 @default.
• W4285097462 hasRelatedWork W2793717011 @default.
• W4285097462 hasRelatedWork W2802577932 @default.
• W4285097462 hasRelatedWork W2802584626 @default.
• W4285097462 hasRelatedWork W2913273475 @default.
• W4285097462 hasRelatedWork W2923211281 @default.
• W4285097462 hasRelatedWork W2944664811 @default.
• W4285097462 hasRelatedWork W4200397779 @default.

• next